Moderna reports positive data in first phase of coronavirus vaccine trial

1:25am PDT - May 18th, 2020    moderna - The Washington Times

Moderna Inc., a Massachusetts-based biotech company, on Monday reported positive interim data in the first phase of a coronavirus vaccine trial, saying some patients who were vaccinated developed antibodies at levels mirroring recovered COVID-19 patients.